Clinical Characteristics of Genital Warts

Etiology and Appearance

• Genital warts are caused by human papillomavirus (HPV) infection, with types 6 and 11 responsible for approximately 90% of cases, according to the Centers for Disease Control and Prevention (CDC) 1, 2

Anatomical Distribution

• Genital warts can occur on multiple anatomical sites including external genitalia, perineum, perianal skin, uterine cervix, vagina, urethra, and anus, as reported by the CDC 1
• Intra-anal warts are predominantly seen in patients with a history of receptive anal intercourse, while perianal warts can occur in individuals without such history, according to the CDC 1, 2

Clinical Symptoms

• Many genital warts are asymptomatic, but when symptomatic, patients may experience pruritus, pain or tenderness, and friability, as noted by the CDC 1

Diagnostic Considerations

• Biopsy is indicated in specific circumstances, including uncertain diagnosis, lesions unresponsive to standard therapy, worsening during therapy, immunocompromised patients, and pigmented or ulcerated lesions, as recommended by the CDC 1
• Type-specific HPV nucleic acid tests are not recommended for routine diagnosis or management, according to the CDC 1

Important Clinical Distinctions

• HPV types 16, 18, 31, 33, and 35 are occasionally found in visible genital warts and are associated with squamous intraepithelial neoplasia and squamous cell carcinoma, as reported by the CDC 1

Natural Course

• If left untreated, genital warts may resolve spontaneously, remain unchanged, or increase in size or number, with most patients having fewer than 10 genital warts with a total area of 0.5-1.0 cm², as noted by the CDC 1
• Warts on moist surfaces or intertriginous areas typically respond better to topical treatments than those on drier surfaces, according to the CDC 3

Treatment Response Characteristics

• Recurrence is common (approximately 30%) regardless of treatment method, as reported by the CDC 4
• Treatment can induce wart-free periods but may not eradicate HPV infection, and current therapies may reduce but probably do not eliminate infectivity, according to the CDC 1
• No evidence indicates that treatment of visible warts affects the development of cervical cancer, as noted by the CDC 2

Special Considerations

• Immunocompromised patients may have more extensive or treatment-resistant warts, as reported by the CDC 1